Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Johnson and Johnson
Chubb
Queensland Health
Fuji
Covington
Cerilliant
Fish and Richardson

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202552

« Back to Dashboard

NDA 202552 describes ACITRETIN, which is a drug marketed by Barr Labs Inc, Impax Labs Inc, Mylan Pharms Inc, Sigmapharm Labs Llc, and Teva Pharms Usa, and is included in six NDAs. It is available from six suppliers. Additional details are available on the ACITRETIN profile page.

The generic ingredient in ACITRETIN is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.
Summary for 202552
Tradename:ACITRETIN
Applicant:Impax Labs Inc
Ingredient:acitretin
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202552
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 202552
Suppliers and Packaging for NDA: 202552
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACITRETIN acitretin CAPSULE;ORAL 202552 ANDA Impax Generics 0115-1667 N 0115-1667-08
ACITRETIN acitretin CAPSULE;ORAL 202552 ANDA Impax Generics 0115-1668 N 0115-1668-08

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Dec 23, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength17.5MG
Approval Date:Dec 23, 2015TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength22.5MG
Approval Date:Dec 23, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
Merck
Citi
Chinese Patent Office
Federal Trade Commission
Moodys
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.